Hüe T, Petermann J, Bonnefond R, Mermoud I, Rantoen D, Vuocolo T. Experimental efficacy of a vaccine against Rhipicephalus australis.
Exp Appl Acarol 2017;
73:245-256. [PMID:
29110171 DOI:
10.1007/s10493-017-0184-0]
[Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2017] [Accepted: 11/01/2017] [Indexed: 06/07/2023]
Abstract
Despite several decades of chemical use the cattle tick, Rhipicephalus australis, still represents an important threat for breeders of tick susceptible cattle under tropical conditions. The intense use of acaricides has lead to the development of multi-resistant strains of ticks and alternative means of control need to be developed to maintain control. A vaccine against ticks, based on the Boophilus microplus Bm86 protein, is one of the promising alternative means of tick control. In this investigation, an experimental vaccine was developed based on the orthologous R. australis Bm86 sequence identified from local R. australis strains and a recombinant protein expressed in Escherichia coli. The efficacy of this vaccine against a local strain of R. australis was assessed under controlled conditions. Vaccinated cattle presented 40.3% fewer ticks than unvaccinated cattle and tick reproductive performance was also affected by the vaccine. Ticks that engorged on vaccinated animals laid 51.2% less egg mass and tick fertility decreased by 18.8% compared to the control group. The use of the vaccine reduced the tick population by 74.2% at each generation. The tick vaccine can be used in an integrated tick control program.
Collapse